Showing 2 of 2 recruiting trials for “Malignant mixed Müllerian tumor of the ovary”
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →